表紙
市場調查報告書
商品編碼
1056642

全球市場(2021-2031):耗材,平台,技術,應用,最終用戶區域由設備,平台,技術,應用,最終用戶區域的最終用戶區域

Cell-Free DNA Isolation and Extraction Market - A Global and Regional Analysis: Focus on Consumables, Platform, Techniques, Application, End User, and Region - Analysis and Forecast, 2021-2031

出版日期: | 出版商: BIS Research Inc. | 英文 230 Pages | 商品交期: 最快1-2個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

世界無細胞DNA分離和提取的市場規模為預測期為1.699億元的14.19%,2031年,達到7.351億美元。預計會增長。

癌症的患病率,增加了主要的企業努力,增加了政府舉措,增加了無細胞DNA分離和提取套件,管和其他耗材。此外,醫療保健公司不斷調查大型投資,以滿足行業的需求,並僱用無細胞DNA分離和提取試劑盒,管和試劑在主要最終用戶之間進展。這也促進了市場的增長。

本報告調查市場定義和概述,新的冠狀病毒感染(Covid-19)和其他市場影響因素分析,分析本報告中的市場影響因素。·我們總結了預測,耗材,平台,技術,應用程序,最終用戶區域/主要國家/地區,包括各個部分,競爭環境,主要公司的簡檔。

內容

第1章全球溶細胞DNA分離和提取市場

  • 產品定義
  • 市場範圍
  • 市場概述

第2章全球細胞 - 細胞DNA分離和提取市場:工業分析

  • 概述
  • 美國的法律要求和框架
  • 歐洲的法律要求和框架
  • 亞太地區的法律要求和框架

第3章市場力學

  • 概述
  • 影響分析
  • 市場促銷原因
  • 市場抑制因子
  • 市場機會

第4章衝突行為

  • 概述
  • 釋放和升級產品
  • 產品和金融部長的批准
  • 具有協同效應的活動
  • 併購
  • 市場份額分析(由公司)
  • 增長份額分析(由企業)

第5章消耗品

  • 概述
  • 細胞 - 細胞DNA分離和提取套件
  • 細胞DNA分離和提取管
  • 其他

第6章平台

  • 概述
  • 下一代測序(ngs)
  • 聚合□鏈反應(PCR)
    • 實時聚合□鏈反應(RT-PCR)
    • 數字聚合□鏈反應(DPCR)
  • 其他

第7章技術

  • 概述
  • 磁珠基
  • 旋轉柱底座
  • 其他

第8章應用

  • 概述
  • 非侵入性出生測試(nipt)
  • 腫瘤
    • 實體瘤
    • 血液惡性腫瘤
  • 移植排斥反應
  • 其他

第9章最終用戶

  • 概述
  • 製藥和生物技術公司 LAB,實驗室學術研究組織
  • CRO
  • 臨床診斷中心
  • 其他

第10章區域

  • 概述
  • 北美
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 其他領域

第11章公司配置文件

  • Thermo Fisher Scientific Inc.
  • QIAGEN
  • Danaher
  • PerkinElmer, Inc.
  • Endress+Hauser AG
  • Agilent Technologies, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Merck KGaA
  • Illumina, Inc.
  • Takara Bio Inc.
  • Aline Biosciences
  • EpiGentek Group, Inc.
  • Omega Bio-tek, Inc.
  • Promega Corporation
  • Streck, Inc.
  • AccuBioMed Co., Ltd.
  • AMSBIO
  • Covaris, Inc.
  • EntroGen, Inc.
  • NeoGeneStar LLC
  • Norgen Biotek Corp.
  • STRATEC SE
  • System Biosciences, LLC
  • Vela Diagnostics
目錄
Product Code: BHP0590SB

“Global Cell-Free DNA Isolation and Extraction Market to Reach $735.1 Million by 2031.”

Market Report Coverage - Cell-Free DNA Isolation and Extraction

Market Segmentation

  • Consumable - Cell-Free DNA Isolation and Extraction Kits, ell-Free DNA Isolation and Extraction Tubes, and Other Consumables
  • Platform - Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), and Other Platforms
  • Technique - Magnetic Beads-Based, Spin Column-Based, and Other Techniques
  • Application - Non-Invasive Prenatal Testing (NIPT), Oncology, Transplant Rejection, and Other Applications
  • End-User - Academic Research Institutes and Laboratories, Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROs), Clinical Diagnostic Centers, and Other End Users

Regional Segmentation

  • North America - U.S., Canada
  • Europe - Germany, U.K., France, Italy, Spain, Denmark, and Rest-of-Europe
  • Asia-Pacific - China, India, Japan, Singapore, South Korea, Australia, and Rest-of-Asia-Pacific
  • Rest-of-the-World

Market Growth Drivers

  • Cell-Free DNA Isolation and Extraction Inclined by Rising Prevalence of Cancer
  • Strategic Initiatives by Key Market Players
  • Rise in the Field of Microbial Sequencing

Market Challenges

  • High Cost of Automated Instruments
  • Genomic Data Protection
  • Rigid Regulatory Standards

Market Opportunities

  • Technological Advancement Toward Innovation in Cell-Free DNA Isolation and Extraction
  • Massive Scope for Adoption of NGS-based Genetic Tests in Emerging Markets

Key Companies Profiled

Thermo Fisher Scientific Inc., QIAGEN, Danaher, PerkinElmer, Inc., Endress+Hauser AG, Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd., Merck KGaA, Illumina, Inc., Takara Bio Inc., Aline Biosciences, EpiGentek Group, Inc., Omega Bio-tek, Inc., Promega Corporation, Streck, Inc., AccuBioMed Co., Ltd., AMSBIO, Covaris, Inc., EntroGen, Inc., NeoGeneStar LLC, Norgen Biotek Corp., STRATEC SE, System Biosciences, LLC, Vela Diagnostics.

Key Questions Answered in this Report:

  • How is cell-free DNA isolation and extraction revolutionizing oncology?
  • What are the major market drivers, challenges, and opportunities in the global cell-free DNA isolation and extraction market?
  • What are the underlying structures resulting in the emerging trends within the global cell-free DNA isolation and extraction market?
  • How is the COVID-19 pandemic impacting the global cell-free DNA isolation and extraction ecosystem?
  • What are the key development strategies that the major players are implementing in order to sustain themselves in the competitive market?
  • What are the key regulatory implications in developed and developing regions pertaining to the use of cell-free DNA isolation and extraction-targeted therapies?
  • What are the potential entry barriers expected to be faced by the companies willing to enter a particular region?
  • How is each market segment expected to grow during the forecast period 2021-2031, and what is the anticipated revenue to be generated by each segment? Following are the segments:
    • Consumable (Cell-Free DNA Isolation and Extraction Kits, Cell-Free DNA Isolation and Extraction Tubes, and Other Consumables)
    • Platform (Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), and Other Platforms)
    • Technique (Magnetic Beads-Based, Spin Column-Based, and Other Techniques)
    • Application (Non-Invasive Prenatal Testing (NIPT), Oncology, Transplant Rejection, and Other Applications)
    • End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutions, Contract Research Organizations (CROs), and Other End Users)
    • Region (North America, Europe, Asia-Pacific, and Rest-of-the-World)
  • What are the growth opportunities for the cell-free DNA isolation and extraction companies in the region of their operation?
  • Who are the leading players with significant offerings in the global cell-free DNA isolation and extraction market?
  • Which companies are anticipated to be highly disruptive in the future, and why?

Market Overview

The use of cell-free DNA isolation and extraction kits, tubes, and other consumables has increased due to the rising prevalence of cancer, the increasing key player initiatives, and the rising government initiatives in the cell-free DNA isolation and extraction market. The constant significant investments by healthcare companies to meet industry demand and the growing adoption of cell-free DNA isolation and extraction kits, tubes, and reagents among major end users are the major factors propelling the growth of the global cell-free DNA isolation and extraction market. The global cell-free DNA isolation and extraction market was valued at $169.9 million in 2020 and is expected to reach $735.1 million by 2031, witnessing a CAGR of 14.19% during the forecast period 2021-2031.

Competitive Landscape

The global cell-free DNA isolation and extraction market comprise well-established and newly emerging companies. Several companies are attempting to sustain their position in the market by launching new products and raising funds to develop new products for the isolation and extraction of cell-free DNA from different sample types. Key market players of the global cell-free DNA isolation and extraction market witnessed product launch, product approval and business funding, and synergistic activities majorly during the period January 2018-November 2021. The inclination of companies toward product launches suggests that the companies are involved in continuously bringing new products to the market to isolate cell-free DNA, which is primarily attributed to an increase in liquid biopsy studies and approval of several liquid biopsy assays by the regulatory agencies.

Table of Contents

1 Global Cell-Free DNA Isolation and Extraction Market

  • 1.1 Product Definition
    • 1.1.1 Inclusion and Exclusion
  • 1.2 Market Scope
    • 1.2.1 Scope of the Study
    • 1.2.2 Key Questions Answered in the Report
  • 1.3 Market Overview
    • 1.3.1 Market Definition
    • 1.3.2 Early Discovery and Application of cfDNA
    • 1.3.3 Properties of cfDNA
    • 1.3.4 Biological Role of cfDNA
    • 1.3.5 Extraction of Circulating cfDNA
    • 1.3.6 Application of Circulating cfDNA
    • 1.3.7 Market Footprint and Growth Potential
    • 1.3.8 Disruption in Global Cell-Free DNA Isolation and Extraction Market Due to COVID-19
    • 1.3.9 COVID-19 Affecting Supply Chain of Global Cell-Free DNA Isolation and Extraction Market
    • 1.3.10 Interruption in Research and Clinical Development and Commercial Operation
      • 1.3.10.1 Research and Clinical Development
      • 1.3.10.2 Commercial Operation
    • 1.3.11 Navigating Crisis Recovery and Looking to the Future

2 Global Cell-Free DNA Isolation and Extraction Market: Industry Analysis

  • 2.1 Overview
  • 2.2 Legal Requirements and Framework in the U.S.
    • 2.2.1 FDA Regulation
  • 2.3 Legal Requirements and Framework in Europe
  • 2.4 Legal Requirements and Framework in Asia-Pacific
    • 2.4.1 China
    • 2.4.2 Japan

3 Market Dynamics

  • 3.1 Overview
  • 3.2 Impact Analysis
  • 3.3 Market Drivers
    • 3.3.1 Cell-Free DNA Isolation and Extraction Inclined by Rising Prevalence of Cancer
    • 3.3.2 Strategic Initiatives by Key Market Players
    • 3.3.3 Rise in the Field of Microbial Sequencing
  • 3.4 Market Restraints
    • 3.4.1 High Cost of Automated Instruments
    • 3.4.2 Genomic Data Protection
    • 3.4.3 Rigid Regulatory Standards
  • 3.5 Market Opportunities
    • 3.5.1 Technological Advancement Toward Innovation in Cell-Free DNA Isolation and Extraction
    • 3.5.2 Massive Scope for Adoption of NGS-based Genetic Tests in Emerging Markets

4 Competitive Landscape

  • 4.1 Overview
  • 4.2 Product Launch and Upgradations
  • 4.3 Product Approvals and Business Funding
  • 4.4 Synergistic Activities
  • 4.5 Mergers and Acquisitions
  • 4.6 Market Share Analysis (by Company), 2019 and 2020
  • 4.7 Growth Share Analysis (by Company)

5 Consumables, $Million, 2020-2031

  • 5.1 Overview
  • 5.2 Cell-Free DNA Isolation and Extraction Kits
  • 5.3 Cell-Free DNA Isolation and Extraction Tubes
  • 5.4 Other Consumables

6 Platform

  • 6.1 Overview
  • 6.2 Next-Generation Sequencing (NGS)
  • 6.3 Polymerase Chain Reaction (PCR)
    • 6.3.1 Real-Time Polymerase Chain Reaction (RT-PCR)
    • 6.3.2 Digital Polymerase Chain Reaction (dPCR)
  • 6.4 Other Platforms

7 Techniques

  • 7.1 Overview
  • 7.2 Magnetic Beads-Based
  • 7.3 Spin Column-Based
  • 7.4 Other Techniques

8 Application

  • 8.1 Overview
  • 8.2 Non-Invasive Prenatal Testing (NIPT)
  • 8.3 Oncology
    • 8.3.1 Solid Tumor
    • 8.3.2 Hematological Malignancies
  • 8.4 Transplant Rejection
  • 8.5 Other Applications

9 End User

  • 9.1 Overview
  • 9.2 Pharmaceutical and Biotechnology Companies
  • 9.3 Academic Research Institutes and Laboratories
  • 9.4 Contract Research Organizations (CROs)
  • 9.5 Clinical Diagnostic Centers
  • 9.6 Other End Users

10 Region

  • 10.1 Overview
  • 10.2 North America
    • 10.2.1 U.S.
    • 10.2.2 Canada
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 France
    • 10.3.3 U.K.
    • 10.3.4 Italy
    • 10.3.5 Spain
    • 10.3.6 Denmark
    • 10.3.7 Rest-of-Europe
  • 10.4 Asia-Pacific
    • 10.4.1 China
    • 10.4.2 India
    • 10.4.3 Japan
    • 10.4.4 South Korea
    • 10.4.5 Australia
    • 10.4.6 Singapore
    • 10.4.7 Rest-of-Asia-Pacific (RoAPAC)
  • 10.5 Latin America
    • 10.5.1 Brazil
    • 10.5.2 Mexico
    • 10.5.3 Rest-of-Latin America (RoLA)
  • 10.6 Rest-of-the-World

11 Company Profiles

  • 11.1 Overview
  • 11.2 Thermo Fisher Scientific Inc.
    • 11.2.1 Company Overview
    • 11.2.2 Role of Thermo Fisher Scientific Inc. in the Global Cell-Free DNA Isolation and Extraction Market
    • 11.2.3 Financials
    • 11.2.4 Key Insights About the Financial Health of the Company
    • 11.2.5 SWOT Analysis
  • 11.3 QIAGEN
    • 11.3.1 Company Overview
    • 11.3.2 Role of QIAGEN in the Global Cell-Free DNA Isolation and Extraction Market
    • 11.3.3 Financials
    • 11.3.4 Key Insights About the Financial Health of the Company
    • 11.3.5 SWOT Analysis
  • 11.4 Danaher
    • 11.4.1 Company Overview
    • 11.4.2 Role of Danaher in the Global Cell-Free DNA Isolation and Extraction Market
    • 11.4.3 Financials
    • 11.4.4 Key Insights About the Financial Health of the Company
    • 11.4.5 SWOT Analysis
  • 11.5 PerkinElmer, Inc.
    • 11.5.1 Company Overview
    • 11.5.2 Role of PerkinElmer, Inc. in the Global Cell-Free DNA Isolation and Extraction Market
    • 11.5.3 Financials
    • 11.5.4 Key Insights About the Financial Health of the Company
    • 11.5.5 SWOT Analysis
  • 11.6 Endress+Hauser AG
    • 11.6.1 Company Overview
    • 11.6.2 Role of Endress+Hauser AG in the Global Cell-Free DNA Isolation and Extraction Market
    • 11.6.3 Financials
    • 11.6.4 Key Insights About the Financial Health of the Company
    • 11.6.5 SWOT Analysis
  • 11.7 Agilent Technologies, Inc.
    • 11.7.1 Company Overview
    • 11.7.2 Role of Agilent Technologies, Inc. in the Global Cell-Free DNA Isolation and Extraction Market
    • 11.7.3 Financials
    • 11.7.4 Key Insights About the Financial Health of the Company
    • 11.7.5 SWOT Analysis
  • 11.8 F. Hoffmann-La Roche Ltd.
    • 11.8.1 Company Overview
    • 11.8.2 Role of F. Hoffmann-La Roche Ltd. in the Global Cell-Free DNA Isolation and Extraction Market
    • 11.8.3 Financials
    • 11.8.4 Key Insights About the Financial Health of the Company
    • 11.8.5 SWOT Analysis
  • 11.9 Merck KGaA
    • 11.9.1 Company Overview
    • 11.9.2 Role of Merck KGaA in the Global Cell-Free DNA Isolation and Extraction Market
    • 11.9.3 Financials
    • 11.9.4 Key Insights About the Financial Health of the Company
    • 11.9.5 SWOT Analysis
  • 11.1 Illumina, Inc.
    • 11.10.1 Company Overview
    • 11.10.2 Role of Illumina, Inc. in the Global Cell-Free DNA Isolation and Extraction Market
    • 11.10.3 Financials
    • 11.10.4 Key Insights About the Financial Health of the Company
    • 11.10.5 SWOT Analysis
  • 11.11 Takara Bio Inc.
    • 11.11.1 Company Overview
    • 11.11.2 Role of Takara Bio Inc. in the Global Cell-Free DNA Isolation and Extraction Market
    • 11.11.3 Financials
    • 11.11.4 Key Insights About the Financial Health of the Company
    • 11.11.5 SWOT Analysis
  • 11.12 Aline Biosciences
    • 11.12.1 Company Overview
    • 11.12.2 Role of Aline Biosciences in the Global Cell-Free DNA Isolation and Extraction Market
    • 11.12.3 SWOT Analysis
  • 11.13 EpiGentek Group, Inc.
    • 11.13.1 Company Overview
    • 11.13.2 Role of EpiGentek Group, Inc. in the Global Cell-Free DNA Isolation and Extraction Market
    • 11.13.3 SWOT Analysis
  • 11.14 Omega Bio-tek, Inc.
    • 11.14.1 Company Overview
    • 11.14.2 Role of Omega Bio-tek, Inc. in the Global Cell-Free DNA Isolation and Extraction Market
    • 11.14.3 SWOT Analysis
  • 11.15 Promega Corporation
    • 11.15.1 Company Overview
    • 11.15.2 Role of Promega Corporation in the Global Cell-Free DNA Isolation and Extraction Market
    • 11.15.3 SWOT Analysis
  • 11.16 Streck, Inc.
    • 11.16.1 Company Overview
    • 11.16.2 Role of Streck, Inc. in the Global Cell-Free DNA Isolation and Extraction Market
    • 11.16.3 SWOT Analysis
  • 11.17 AccuBioMed Co., Ltd.
    • 11.17.1 Company Overview
    • 11.17.2 Role of AccuBioMed Co., Ltd. in the Global Cell-Free DNA Isolation and Extraction Market
  • 11.18 AMSBIO
    • 11.18.1 Company Overview
    • 11.18.2 Role of AMSBIO in the Global Cell-Free DNA Isolation and Purification Market
  • 11.19 Covaris, Inc.
    • 11.19.1 Role of Covaris, Inc. in the Global Cell-Free DNA Isolation and Extraction Market
  • 11.2 EntroGen, Inc.
    • 11.20.1 Role of EntroGen, Inc. in the Global Cell-Free DNA Isolation and Extraction Market
  • 11.21 NeoGeneStar LLC
    • 11.21.1 Company Overview
    • 11.21.2 Role of NeoGeneStar LLC in the Global Cell-Free DNA Isolation and Extraction Market
  • 11.22 Norgen Biotek Corp.
    • 11.22.1 Company Overview
    • 11.22.2 Role of Norgen Biotek Corp. in the Global Cell-Free DNA Isolation and Extraction Market
  • 11.23 STRATEC SE
    • 11.23.1 Company Overview
    • 11.23.2 Role of STRATEC SE in the Global Cell-Free DNA Isolation and Extraction Market
  • 11.24 System Biosciences, LLC
    • 11.24.1 Company Overview
    • 11.24.2 Role of System Biosciences, LLC in the Global Cell-Free DNA Isolation and Extraction Market
  • 11.25 Vela Diagnostics
    • 11.25.1 Company Overview
    • 11.25.2 Role of Vela Diagnostics in the Global Cell-Free DNA Isolation and Extraction Market

List of Figures

  • Figure 1: Global Cancer Burden, 2020
  • Figure 2: Impact Analysis of Market Drivers and Market Challenges on the Global Cell-Free DNA Isolation and Extraction Market
  • Figure 3: Global Cell-Free DNA Isolation and Extraction Market (by Consumable), $Million, 2020 and 2031
  • Figure 4: Global Cell-Free DNA Isolation and Extraction Market (by Technique), $Million, 2020 and 2031
  • Figure 5: Global Cell-Free DNA Isolation and Extraction Market (by Platform), $Million, 2020 and 2031
  • Figure 6: Global Cell-Free DNA Isolation and Extraction Market (by Application), $Million, 2020 and 2031
  • Figure 7: Global Cell-Free DNA Isolation and Extraction Market (by End User), $Million, 2020 and 2031
  • Figure 8: Global Cell-Free DNA Isolation and Extraction Market Snapshot
  • Figure 9: Global Cell-Free DNA Isolation and Extraction Market: Research Methodology
  • Figure 10: Primary Research Methodology
  • Figure 11: Bottom-Up Approach (Segment-Wise Analysis)
  • Figure 12: Top-Down Approach (Segment-Wise Analysis)
  • Figure 13: Global Cell-Free DNA Isolation and Extraction Market Segmentation
  • Figure 14: Global Cell-Free DNA Isolation and Extraction Market, $Million, 2020-2031
  • Figure 15: Global Cell-Free DNA Isolation and Extraction Market: COVID-19 Impact Analysis
  • Figure 16: Overview of Regulatory Process for Medical Devices by FDA
  • Figure 17: Overview of Regulatory Process for Medical Devices in Europe
  • Figure 18: Overview of Regulatory Process for Medical Devices by National Medical Product Administration
  • Figure 19: Global Cancer Burden, 2020
  • Figure 20: Share of Key Developments, January 2018-November 2021
  • Figure 21: Share of Product Launch and Upgradations (by Company), January 2018-November 2021
  • Figure 22: Share of Product Approvals and Business Funding (by Company), January 2018-November 2021
  • Figure 23: Share of Synergistic Activities (by Company), January 2018-November 2021
  • Figure 24: Market Share Analysis of Global Cell-Free DNA Isolation and Extraction Market (by Company), 2019 and 2020
  • Figure 25: Growth Share Analysis for Global Cell-Free DNA Isolation and Extraction Market (by Company), 2020
  • Figure 26: Global Cell-Free DNA Isolation and Extraction Market Segmentation (by Consumable)
  • Figure 27: Global Cell-Free DNA Isolation and Extraction Market (by Consumable), $Million, 2020 and 2031
  • Figure 28: Global Cell-Free DNA Isolation and Extraction Market (Cell-Free DNA Isolation and Extraction Kits), $Million, 2020-2031
  • Figure 29: Global Cell-Free DNA Isolation and Extraction Market (Cell-Free DNA Isolation and Extraction Kits), Unit, 2020-2031
  • Figure 30: Global Cell-Free DNA Isolation and Extraction Market (Cell-Free DNA Isolation and Extraction Tubes), $Million, 2020-2031
  • Figure 31: Global Cell-Free DNA Isolation and Extraction Market (Other Consumables), $Million, 2020-2031
  • Figure 32: Global Cell-Free DNA Isolation and Extraction Market Segmentation (by Platform)
  • Figure 33: Global Cell-Free DNA Isolation and Extraction Market (by Platform), $Million, 2020 and 2031
  • Figure 34: Global Cell-Free DNA Isolation and Extraction Market (Next-Generation Sequencing), $Million, 2020-2031
  • Figure 35: Global Cell-Free DNA Isolation and Extraction Market (Next-Generation Sequencing (NGS)), Unit, 2020-2031
  • Figure 36: Global Cell-Free DNA Isolation and Extraction Market (Polymerase Chain Reaction (PCR)), $Million, 2020-2031
  • Figure 37: Global Cell-Free DNA Isolation and Extraction Market (Polymerase Chain Reaction (PCR)), Unit, 2020-2031
  • Figure 38: Global Cell-Free DNA Isolation and Extraction Market (Real-Time Polymerase Chain Reaction (RT-PCR)), $Million, 2020-2031
  • Figure 39: Global Cell-Free DNA Isolation and Extraction Market (Real-Time Polymerase Chain Reaction (RT-PCR)), Unit, 2020-2031
  • Figure 40: Global Cell-Free DNA Isolation and Extraction Market (Digital Polymerase Chain Reaction (dPCR)), $Million, 2020-2031
  • Figure 41: Global Cell-Free DNA Isolation and Extraction Market (Digital Polymerase Chain Reaction (dPCR), Unit, 2020-2031
  • Figure 42: Global Cell-Free DNA Isolation and Extraction Market (Other Platforms), $Million, 2020-2031
  • Figure 43: Global Cell-free DNA Isolation and Extraction Market (Other Platforms), Unit, 2020-2031
  • Figure 44: Global Cell-Free DNA Isolation and Extraction Market (by Technique)
  • Figure 45: Global Cell-Free DNA Isolation and Extraction Market (by Technique), $Million, 2020 and 2031
  • Figure 46: Global Cell-Free DNA Isolation and Extraction Market (Magnetic Beads-Based Technique), $Million, 2020-2031
  • Figure 47: Global Cell-Free DNA Isolation and Extraction Market (Spin Column-Based Technique), $Million, 2020-2031
  • Figure 48: Global Cell-Free DNA Isolation and Extraction Market (Other Techniques), $Million, 2020-2031
  • Figure 49: Global Cell-Free DNA Isolation and Extraction Market (by Application)
  • Figure 50: Global Cell-Free DNA Isolation and Extraction Market (by Application), $Million, 2020 and 2031
  • Figure 51: Global Cell-Free DNA Isolation and Extraction Market (Non-Invasive Prenatal Testing (NIPT)), $Million, 2020-2031
  • Figure 52: Global Cell-Free DNA Isolation and Extraction Market (Non-Invasive Prenatal Testing (NIPT), Unit, 2020-2031
  • Figure 53: Global Cell-Free DNA Isolation and Extraction Market (Oncology), $Million, 2020-2031
  • Figure 54: Global Cell-Free DNA Isolation and Extraction Market (Oncology), Unit, 2020-2031
  • Figure 55: Global Cell-Free DNA Isolation and Extraction Market (Solid Tumor), $Million, 2020-2031
  • Figure 56: Global Cell-Free DNA Isolation and Extraction Market (Hematological Malignancies), $Million, 2020-2031
  • Figure 57: Global Cell-Free DNA Isolation and Extraction Market (Transplant Rejection), $Million, 2020-2031
  • Figure 58: Global Cell-Free DNA Isolation and Extraction Market (Transplant Rejection), Unit, 2020-2031
  • Figure 59: Global Cell-Free DNA Isolation and Extraction Market (Other Applications), $Million, 2020-2031
  • Figure 60: Global Cell-Free DNA Isolation and Extraction Market (Other Applications), Unit, 2020-2031
  • Figure 61: Global Cell-Free DNA Isolation and Extraction Market (by End User)
  • Figure 62: Global Cell-Free DNA Isolation and Extraction Market (by End User), $Million, 2020 and 2031
  • Figure 63: Global Cell-Free DNA Isolation and Extraction Market (Pharmaceutical and Biotechnology Companies), $Million, 2020-2031
  • Figure 64: Global Cell-Free DNA Isolation and Extraction Market (Pharmaceutical and Biotechnology Companies), Unit, 2020-2031
  • Figure 65: Global Cell-Free DNA Isolation and Extraction Market (Academic Research Institutes and Laboratories), $Million, 2020-2031
  • Figure 66: Global Cell-Free DNA Isolation and Extraction Market (Academic and Research Institutes and Laboratories), Unit, 2020-2031
  • Figure 67: Global Cell-Free DNA Isolation and Extraction Market (Contract Research Organizations), $Million, 2020-2031
  • Figure 68: Global Cell-Free DNA Isolation and Extraction Market (Contract Research Organizations), Unit, 2020-2031
  • Figure 69: Global Cell-Free DNA Isolation and Extraction Market (Clinical Diagnostics Centers), $Million, 2020-2031
  • Figure 70: Global Cell-Free DNA Isolation and Extraction Market (Clinical Diagnostics Centers), Unit, 2020-2031
  • Figure 71: Global Cell-Free DNA Isolation and Extraction Market (Other End Users), $Million, 2020-2031
  • Figure 72: Global Cell-Free DNA Isolation and Extraction Market (Other End Users), Unit, 2020-2031
  • Figure 73: Global Cell-Free DNA Isolation and Extraction Market Snapshot (by Region), $Million, 2020-2031
  • Figure 74: Global Cell-Free DNA Isolation and Extraction Market (by Region), $Million, 2020-2031
  • Figure 75: Global Cell-Free DNA Isolation and Extraction Market (by Region), $Million, 2020 and 2031
  • Figure 76: North America Cell-Free DNA Isolation and Extraction Market, $Million, 2020-2031
  • Figure 77: North America: Market Dynamics
  • Figure 78: North America Cell-Free DNA Isolation and Extraction Market (by Country), $Million, 2020-2031
  • Figure 79: North America Cell-Free DNA Isolation and Extraction Kits Market, Unit, 2020-2031
  • Figure 80: U.S. Cell-Free DNA Isolation and Extraction Market, $Million, 2020-2031
  • Figure 81: U.S. Cell-Free DNA Isolation and Extraction Kits Market, $Million, 2020-2031
  • Figure 82: U.S. Cell-Free DNA Isolation and Extraction Kits Market, Unit, 2020-2031
  • Figure 83: Canada Cell-Free DNA Isolation and Extraction Market, $Million, 2020-2031
  • Figure 84: Canada Cell-Free DNA Isolation and Extraction Kits Market, $Million, 2020-2031
  • Figure 85: Canada Cell-Free DNA Isolation and Extraction Kits Market, Unit, 2020-2031
  • Figure 86: Europe Cell-Free DNA Isolation and Extraction Market, $Million, 2020-2031
  • Figure 87: Europe: Market Dynamics
  • Figure 88: Europe Cell-Free DNA Isolation and Extraction Market (by Country), $Million, 2020-2031
  • Figure 89: Europe Cell-Free DNA Isolation and Extraction Kits Market, $Million, 2020-2031
  • Figure 90: Europe Cell-Free DNA Isolation and Extraction Market, Unit, 2020-2031
  • Figure 91: Germany Cell-Free DNA Isolation and Extraction Market, $Million, 2020-2031
  • Figure 92: Germany Cell-Free DNA Isolation and Extraction Kits Market, $Million, 2020-2031
  • Figure 93: Germany Cell-Free DNA Isolation and Extraction Market, Unit, 2020-2031
  • Figure 94: France Cell-Free DNA Isolation and Extraction Market, $Million, 2020-2031
  • Figure 95: France Cell-Free DNA Isolation and Extraction Kits Market, $Million, 2020-2031
  • Figure 96: France Cell-Free DNA Isolation and Extraction Market, Unit, 2020-2031
  • Figure 97: U.K. Cell-Free DNA Isolation and Extraction Market, $Million, 2020-2031
  • Figure 98: U.K. Cell-Free DNA Isolation and Extraction Kits Market, $Million, 2020-2031
  • Figure 99: U.K. Cell-Free DNA Isolation and Extraction Kits Market, Unit, 2020-2031
  • Figure 100: Italy Cell-Free DNA Isolation and Extraction Market, $Million, 2020-2031
  • Figure 101: Italy Cell-Free DNA Isolation and Extraction Kits Market, $Million, 2020-2031
  • Figure 102: Italy Cell-Free DNA Isolation and Extraction Kits Market, Unit, 2020-2031
  • Figure 103: Spain Cell-Free DNA Isolation and Extraction Market, $Million, 2020-2031
  • Figure 104: Spain Cell-Free DNA Isolation and Extraction Kits Market, $Million, 2020-2031
  • Figure 105: Spain Cell-Free DNA Isolation and Extraction Kits Market, Unit, 2020-2031
  • Figure 106: Denmark Cell-Free DNA Isolation and Extraction Market, $Million, 2020-2031
  • Figure 107: Denmark Cell-Free DNA Isolation and Extraction Kits Market, $Million, 2020-2031
  • Figure 108: Denmark Cell-Free DNA Isolation and Extraction Market, Unit, 2020-2031
  • Figure 109: Rest-of-Europe Cell-Free DNA Isolation and Extraction Market, $Million, 2020-2031
  • Figure 110: Rest-of-Europe Cell-Free DNA Isolation and Extraction Kits Market, $Million, 2020-2031
  • Figure 111: Rest-of-Europe Cell-Free DNA Isolation and Extraction Market, Unit, 2020-2031
  • Figure 112: Asia-Pacific Cell-Free DNA Isolation and Extraction Market, $Million, 2020-2031
  • Figure 113: Asia-Pacific: Market Dynamics
  • Figure 114: APAC Cell-Free DNA Isolation and Extraction Market (by Country), $Million, 2020-2031
  • Figure 115: China Cell-Free DNA Isolation and Extraction Market, $Million, 2020-2031
  • Figure 116: India Cell-Free DNA Isolation and Extraction Market, $Million, 2020-2031
  • Figure 117: Japan Cell-Free DNA Isolation and Extraction Market, $Million, 2020-2031
  • Figure 118: South Korea Cell-Free DNA Isolation and Extraction Market, $Million, 2020-2031
  • Figure 119: Australia Cell-Free DNA Isolation and Extraction Market, $Million, 2020-2031
  • Figure 120: Singapore Cell-Free DNA Isolation and Extraction Market, $Million, 2020-2031
  • Figure 121: RoAPAC Cell-Free DNA Isolation and Extraction Market, $Million, 2020-2031
  • Figure 122: Latin America Cell-Free DNA Isolation and Extraction Market, $Million, 2020-2031
  • Figure 123: Latin America: Market Dynamics
  • Figure 124: Latin America Cell-Free DNA Isolation and Extraction Market (by Country), $Million, 2020-2031
  • Figure 125: Brazil Cell-Free DNA Isolation and Extraction Market, $Million, 2020-2031
  • Figure 126: Mexico Cell-Free DNA Isolation and Extraction Market, $Million, 2020-2031
  • Figure 127: Rest-of-Latin America (RoLA) Cell-Free DNA Isolation and Extraction Market, $Million, 2020-2031
  • Figure 128: Rest-of-the-World (RoW) Cell-Free DNA Isolation and Extraction Market, $Million, 2020-2031
  • Figure 129: Total Number of Companies Profiled
  • Figure 130: Thermo Fisher Scientific Inc.: Product Portfolio
  • Figure 131: Thermo Fisher Scientific Inc.: Overall Financials, $Million, 2018-2020
  • Figure 132: Thermo Fisher Scientific Inc.: Revenue (by Segment), $Million, 2018-2020
  • Figure 133: Thermo Fisher Scientific Inc.: Revenue (by Region), $Million, 2018-2020
  • Figure 134: Thermo Fisher Scientific Inc.: R&D Expenditure, $Million, 2018-2020
  • Figure 135: Thermo Fisher Scientific Inc.: SWOT Analysis
  • Figure 136: QIAGEN: Product Portfolio
  • Figure 137: QIAGEN: Overall Financials, $Million, 2018-2020
  • Figure 138: QIAGEN N.V.: Revenue (by Segment), $Million, 2018-2020
  • Figure 139: QIAGEN N.V.: Revenue (by Region), $Million, 2018-2020
  • Figure 140: QIAGEN N.V.: R&D Expenditure, $Million, 2018-2020
  • Figure 141: QIAGEN N.V.: SWOT Analysis
  • Figure 142: Danaher: Product Portfolio
  • Figure 143: Danaher Corporation: Overall Financials, $Million, 2018-2020
  • Figure 144: Danaher: Revenue (by Segment), $Million, 2018-2020
  • Figure 145: Danaher: Revenue (by Region), $Million, 2018-2020
  • Figure 146: Danaher: R&D Expenditure, $Million, 2018-2020
  • Figure 147: Danaher: SWOT Analysis
  • Figure 148: PerkinElmer, Inc.: Product Portfolio
  • Figure 149: PerkinElmer, Inc.: Overall Financials, $Million, 2018-2020
  • Figure 150: PerkinElmer, Inc.: Revenue (by Segment), $Million, 2018-2020
  • Figure 151: PerkinElmer, Inc.: Revenue (by Region), $Million, 2018-2020
  • Figure 152: PerkinElmer, Inc.: R&D Expenditure, $Million, 2018-2020
  • Figure 153: PerkinElmer, Inc.: SWOT Analysis
  • Figure 154: Endress+Hauser AG: Product Portfolio
  • Figure 155: Endress+Hauser AG: Overall Financials, $Million, 2018-2020
  • Figure 156: Endress+Hauser AG: Revenue (by Segment), $Million, 2018-2020
  • Figure 157: Endress+Hauser AG: Revenue (by Region), $Million, 2018-2020
  • Figure 158: Endress+Hauser AG: R&D Expenditure, $Million, 2018-2020
  • Figure 159: Endress+Hauser AG: SWOT Analysis
  • Figure 160: Agilent Technologies, Inc.: Product Portfolio
  • Figure 161: Agilent Technologies, Inc.: Overall Financials, $Million, 2018-2020
  • Figure 162: Agilent Technologies, Inc.: Revenue (by Segment), $Million, 2018-2020
  • Figure 163: Agilent Technologies, Inc.: Revenue (by Region), $Million, 2018-2020
  • Figure 164: Agilent Technologies, Inc.: R&D Expenditure, $Million, 2018-2020
  • Figure 165: Agilent Technologies, Inc.: SWOT Analysis
  • Figure 166: F. Hoffmann-La Roche Ltd.: Product Portfolio
  • Figure 167: F. Hoffmann-La Roche Ltd.: Overall Financials, $Million, 2018-2020
  • Figure 168: F. Hoffmann-La Roche Ltd.: Revenue (by Segment), $Million, 2018-2020
  • Figure 169: F. Hoffmann-La Roche Ltd.: Revenue (by Region), $Million, 2018-2020
  • Figure 170: F. Hoffmann-La Roche Ltd.: R&D Expenditure, $Million, 2018-2020
  • Figure 171: F. Hoffmann-La Roche Ltd.: SWOT Analysis
  • Figure 172: Merck KGaA: Product Portfolio
  • Figure 173: Merck KGaA: Overall Financials, $Million, 2018-2020
  • Figure 174: Merck KGaA: Revenue (by Segment), $Million, 2018-2020
  • Figure 175: Merck KGaA: Revenue (by Region), $Million, 2018-2020
  • Figure 176: Merck KGaA: R&D Expenditure, $Million, 2018-2020
  • Figure 177: Merck KGaA: SWOT Analysis
  • Figure 178: Illumina, Inc.: Product Portfolio
  • Figure 179: Illumina, Inc.: Overall Financials, $Million, 2018-2020
  • Figure 180: Illumina, Inc.: Revenue (by Segment), $Million, 2018-2020
  • Figure 181: Illumina, Inc.: Revenue (by Region), $Million, 2018-2020
  • Figure 182: Illumina, Inc.: R&D Expenditure, $Million, 2018-2020
  • Figure 183: Illumina, Inc.: SWOT Analysis
  • Figure 184: Takara Bio Inc.: Product Portfolio
  • Figure 185: Takara Bio Inc.: Overall Financials, $Million, 2018-2020
  • Figure 186: Takara Bio Inc.: Revenue (by Segment), $Million, 2018-2020
  • Figure 187: Takara Bio Inc.: Revenue (by Region), $Million, 2018-2020
  • Figure 188: Takara Bio Inc.: R&D Expenditure, $Million, 2018-2021
  • Figure 189: Takara Bio Inc.: SWOT Analysis
  • Figure 190: Aline Biosciences: Product Portfolio
  • Figure 191: Aline Biosciences: SWOT Analysis
  • Figure 192: EpiGentek Group, Inc.: Product Portfolio
  • Figure 193: EpiGentek Group, Inc.: SWOT Analysis
  • Figure 194: Omega Bio-tek, Inc.: Product Portfolio
  • Figure 195: Omega Bio-tek, Inc.: SWOT Analysis
  • Figure 196: Promega Corporation: Product Portfolio
  • Figure 197: Promega Corporation: SWOT Analysis
  • Figure 198: Streck, Inc.: Product Portfolio
  • Figure 199: Streck, Inc.: SWOT Analysis
  • Figure 200: AccuBioMed Co., Ltd.: Product Portfolio
  • Figure 201: AMSBIO: Product Portfolio
  • Figure 202: Covaris, Inc.: Product Portfolio
  • Figure 203: EntroGen, Inc.: Product Portfolio
  • Figure 204: NeoGeneStar LLC: Product Portfolio
  • Figure 205: Norgen Biotek Corp.: Product Portfolio
  • Figure 206: STRATEC SE: Product Portfolio
  • Figure 207: System Biosciences, LLC: Product Portfolio
  • Figure 208: Vela Diagnostics: Product Portfolio

List of Tables

  • Table 1: Classification of Medical Device
  • Table 2: Likert Scale
  • Table 3: Impact Analysis of Market Drivers
  • Table 4: Impact Analysis of Market Restraints
  • Table 5: Cell-Free DNA Isolation and Extraction Tubes Offered by Key Market Players
  • Table 6: List of Kits Using Spin Column-Based Technique